Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Safety and efficacy comparison between OACs plus single antiplatelet and dual antiplatelet therapy in patients with cerebral venous sinus stenosis poststenting

Fig. 1

Design of drug flow chart of CVSS before and after treatment: LMWH indicates low-molecular-weight heparin. Dual antiplatelet group: clopidogrel 75 mg and aspirin 100 mg for 12 months. OACs group: aspirin 100 mg or clopidogrel 75 mg plus warfarin or NOACs for 12 months

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us